 |
(6aR, 10aR)-3-(1’,1’-dimethylheptyl)-Δ8-tetrahydro-cannabinol-9-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-10 00:00:00 |
| Sponsor | Corbus Pharmaceuticals, Inc.;100 River Ridge Drive, Suite 103;Norwood, MA, 02062 |
